share_log

Oppenheimer Maintains Outperform on Incyte, Lowers Price Target to $84

Benzinga ·  Apr 24 19:22

Oppenheimer analyst Jay Olson maintains Incyte (NASDAQ:INCY) with a Outperform and lowers the price target from $92 to $84.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment